Correlation Between Psychemedics and BioAffinity Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Psychemedics and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Psychemedics and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Psychemedics and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Psychemedics and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Psychemedics with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Psychemedics and BioAffinity Technologies.

Diversification Opportunities for Psychemedics and BioAffinity Technologies

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Psychemedics and BioAffinity is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Psychemedics and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Psychemedics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Psychemedics are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Psychemedics i.e., Psychemedics and BioAffinity Technologies go up and down completely randomly.

Pair Corralation between Psychemedics and BioAffinity Technologies

Considering the 90-day investment horizon Psychemedics is expected to generate 29.27 times less return on investment than BioAffinity Technologies. But when comparing it to its historical volatility, Psychemedics is 42.54 times less risky than BioAffinity Technologies. It trades about 0.09 of its potential returns per unit of risk. bioAffinity Technologies Warrant is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  78.00  in bioAffinity Technologies Warrant on August 31, 2024 and sell it today you would lose (6.00) from holding bioAffinity Technologies Warrant or give up 7.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Psychemedics  vs.  bioAffinity Technologies Warra

 Performance 
       Timeline  
Psychemedics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Psychemedics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Psychemedics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
BioAffinity Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Psychemedics and BioAffinity Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Psychemedics and BioAffinity Technologies

The main advantage of trading using opposite Psychemedics and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Psychemedics position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.
The idea behind Psychemedics and bioAffinity Technologies Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets